FDA says infant formula supply safe
- The FDA said on April 29 the U.S. infant formula supply is safe after its biggest-ever contaminant review of products sold nationwide. - The agency tested more than 300 samples — 312 across 16 brands — and generated over 120,000 data points on metals and chemicals. - This matters because formula trust never fully recovered after the 2022 shortage, and the FDA is now promising more testing.
Infant formula is one of those products where “mostly fine” does not feel like enough. Parents want a simple answer — is this safe for my baby or not? On April 29, the FDA gave the clearest version of that answer it has offered in years: yes, the U.S. infant formula supply is safe after the agency’s biggest contaminant testing effort ever. But the real story is not just reassurance. It is that the FDA is trying to rebuild trust in a market that got badly shaken in 2022 and has stayed under a microscope since. (fda.gov) ### What did the FDA actually do? The agency tested more than 300 formula samples sold at retail in the U.S. — 312 samples across 16 brands, based on outside coverage that cites the release in more detail. Those samples covered powdered formula, ready-to-feed liquid, and concentrated liquid products. The FDA said the work produced more than 120,000 data points. (fda.gov) ### What was it looking for? This was a contaminants sweep, not a nutrition check. The FDA looked for lead, mercury, cadmium, arsenic, pesticides including glyphosate and glufosinate, PFAS — the “forever chemicals” people worry about in water and food packaging — and phthalates. That lis(fda.gov)exposure from a product many babies rely on every day. (fda.gov) ### So what did it find? The short version is reassuring. The FDA said an overwhelming majority of samples had either undetectable or very low contaminant levels, and that those results affirm the U.S. infant formula supply is safe. The agency did not present this as “problem solved forever,” though. It also said small exposures still matter for newborns and that follow-up testing is already underway. (fda.gov) ### Why are people still uneasy? Because “safe” and “zero contaminants” are not the same thing. Consumer Reports, which helped push this issue into public view with its own formula investigations in 2025 and 2026, welcomed the FDA release but argued that some results and some safety thre(fda.gov)ugh for infants?” (consumerreports.org) ### Where did this testing push come from? A lot of it traces back to Operation Stork Speed, the FDA-HHS initiative launched on March 18, 2025. That program bundled several things together — more contaminant testing, a broad nutrient review, more transparency, and closer work with manufacturers. The April 29 release is one of the first big public outputs from that effort. (fda.gov) ### Why does the 2022 shortage still matter here? Because that crisis broke confidence in both supply and oversight. After Abbott’s 2022 recall and the nationwide shortages that followed, formula stopped feeling like a boring, stable grocery item. It(fda.gov)ch more aggressively than before. (fda.gov) ### What happens next? More testing, for one. The FDA says it will keep sampling formula, including newer products entering the U.S. market, keep talking with manufacturers about where contaminants enter the supply chain, and work toward action levels for contaminants in infant formula. That last part is important — parents got a safety verdict this week, but the rulebook is still getting sharper. (fda.gov) ### Bottom line The FDA did not say infant formula is chemically perfect. It said the products on shelves are safe based on the biggest contaminant review it has ever run. For parents, that is meaningful reassurance. For regulators and manufacturers, it is also a warning — this category is now under sustained scrutiny, and the data trail is only getting denser. (fda.gov)